Ultime notizie per FTI Consulting (NYSE:FCN) Azioni

FTI Consulting

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

FTI Consulting Inc

First Citizens BancShares, Inc. - Class A Common Stock

First Citizens BancShares Inc

FIRST CTZNS BANCSHS B by First Citizens BancShares, Inc.

First Citizens BancShares, Inc. - 5.625% Non-Cumulative Perpetual Preferred Stock, Series C

First Citizens BancShares, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 5.375% Non-Cumulative Perpetual Preferred Stock, Series A

Four Corners Inc. Com

WIIM

FTI Consulting shares are trading lower after the company reported worse-than-expected Q3 financial results.

FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) reported quarterly earnings of $1.85 per share which missed the analyst consensus estimate of $2.06 by 10.19 percent. The company reported quarterly sales of $926.000 million which missed the analyst consensus estimate of $946.204 million by 2.14 percent. This is a 3.67 percent increase over sales of $893.261 million the same period last year.

Earnings

Earnings Misses

News

FTI Consulting Q3 2024 Adj. EPS $1.85 Misses $2.06 Estimate, Sales $926.000M Miss $946.204M Estimate

Truist Securities analyst Tobey Sommer maintains FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) with a Buy and raises the price target from $255 to $275.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on FTI Consulting, Raises Price Target to $275

FTI Consulting Bolsters Global Construction Practice With Senior Appointments In Houston And Dubai

FTI Consulting Announced The Appointment Of Nathan Ramsey As A Senior Managing Director In The Food, Agriculture & Beverage Practice Within The Firm's Corporate Finance & Restructuring Segment

Guidance

FTI Consulting Revises FY24 Revenue Forecast From $3.65B-$3.79B To $3.70B - $3.79B (Est $3.77B); EPS Forecast From $7.75 - $8.50 To $8.10 - $8.60 (Est $8.45)

FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) reported quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $2.04 by 14.71 percent. This is a 33.71 percent increase over earnings of $1.75 per share from the same period last year. The company reported quarterly sales of $949.156 million which beat the analyst consensus estimate of $938.675 million by 1.12 percent. This is a 9.78 percent increase over sales of $864.591 million the same period last year.

Earnings Beats

FTI Consulting Q2 2024 GAAP EPS $2.34 Beats $2.04 Estimate, Sales $949.156M Beat $938.675M Estimate

FTI Consulting Says It Unveiled Cross-Segment Digital Offering That Leverages FTI Consulting's Industry Expertise Across The Digital Landscape

FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $1.87 by 19.25 percent. This is a 66.42 percent increase over earnings of $1.34 per share from the same period last year. The company reported quarterly sales of $928.55 million which beat the analyst consensus estimate of $901.93 million by 2.95 percent. This is a 15.10 percent increase over sales of $806.71 million the same period last year.

FTI Consulting Q1 EPS $2.23 Beats $1.87 Estimate, Sales $928.55M Beat $901.93M Estimate

FTI Consulting, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) today announced that it has acquired Madison Consulting Group, an actuarial consulting firm with 25 billable professionals and offices in Madison, Ga., and Newtown Square, Pa. The addition of Madison Consulting Group expands the firm&#39;s property and casualty actuarial and compliance offerings within the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=FQQlqHWsrAkwgHk5-KryqdWKzSTheHtIMateTClco0HCoL2O16KmizGJk4D_HesM1HYAOzsPsnKst49kHr58VUvgfbLfN1e5I3iWWiIUTUAO9PazpjB5D6ujQJHpxPUqOx26Af8xgA-9q5s9TsMkkQ==" target="_blank">Global Insurance Services</a>&nbsp;practice in the Forensic and Litigation Consulting segment. Terms of the transaction were not disclosed.

FTI Consulting Snapped Madison Consulting Group, Financial Terms Undisclosed

Shares of Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) fell sharply during Thursday&rsquo;s session after the company reported <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37261895/4-etsy-analysts-stand-firm-on-ratings-post-q4-earnings-point-to-buyer-growth-fee-ex">mixed fourth-quarter financial results.</a>
Etsy reported quarterly earnings of 62 cents per share which missed the analyst consensus estimate of 78 cents. The company reported quarterly sales of $842.3 million, beating the analyst consensus estimate of $827.81 million. 
Etsy shares dipped 7.5% to $71.34 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) shares jumped 160.7% to $3.6499 after the company said it has acquired a 100% interest in the Company&#39;s franchisee - La Rosa Realty Winter Garden LLC located in Winter Garden, Florida.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) jumped 91.4% to $0.4150 after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed&rsquo;s workforce.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) rose 80.7% to $1.03 after the company disclosed promising preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) shares gained 40.8% to $12.21 after posting better-than-expected fourth-quarter results.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) jumped 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax&#39;s prototype Covid-19 vaccine (NVX-COV2373).</li>
<li>EZFill Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezfl#NASDAQ">EZFL</a>) rose 34.3% to $1.86. EzFill announced preliminary 2023 revenues of $23 million, up 54% year over year.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) jumped 30% to $2.93.</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) gained 27.6% to $15.00 following upbeat earnings.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) shares climbed 26.9% to $1.6242 after the company received CE Mark from DEKRA Certification B.V. to market Venus Versa Pro in Europe.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 26% to $4.0680 following upbeat results.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 22.2% to $9.19 after announcing a $325.0 million private placement.</li>
<li>Remitly Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rely#NASDAQ">RELY</a>) shares rose 19.5% to $21.13 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) gained 19.3% to $18.13. B. Riley&rsquo;s board issued a statement regarding internal review.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) jumped 19.2% to $875.07. Supermicro announced a proposed offering of $1.5 billion of convertible senior notes due 2029.</li>
<li>Bone Biologics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bblg#NASDAQ">BBLG</a>) gained 18.4% to $3.73.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) rose 17.5% to $18.00 following strong sales results.</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) gained 16.9% to $16.37 after the company reported better-than-expected fourth-quarter financial results and announced the settlement of its antitrust litigation related to the AutoIMS technology platform.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) jumped 15.5% to $219.72 following upbeat results.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) rose 15.4% to $778.61 after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.</li>
<li>OUTFRONT Media Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/out#NYSE">OUT</a>) gained 15.4% to $14.35 following upbeat results.</li>
<li>Lantheus Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnth#NASDAQ">LNTH</a>) rose 14.4% to $64.90 following strong results.</li>
<li>Enerplus Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/erf#NYSE">ERF</a>) rose 13.7% to $18.67.</li>
<li>Indivior PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indv#NASDAQ">INDV</a>) gained 13.3% to $19.83 following fourth-quarter results.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 12.2% to $13.88.</li>
<li>Agile Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agrx#NASDAQ">AGRX</a>) gained 11.1% to $1.10. Agile Therapeutics was granted extension by Nasdaq Hearings Panel to regain compliance until March 25, 2024. The company sees FY23 revenue of $20 million to $21 million. Agile Therapeutics announces exercise of warrants for $4.8 million gross proceeds.</li>
<li>Synopsys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) gained 10.7% to $601.93 after the company reported better-than-expected first-quarter adjusted EPS results and issued strong guidance.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) rose 9.5% to $45.82 following strong results.</li>
<li>Eastside Distilling, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/east#NASDAQ">EAST</a>) shares rose 7.6% to $1.0340.</li>
<li>DigitalOcean Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docn#NYSE">DOCN</a>) gained 6.8% to $38.29 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Draganfly Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dpro#NASDAQ">DPRO</a>) shares fell 50.3% to $0.1790 after the company announced pricing of $3.6 million underwritten public offering.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) fell 46.6% to $0.2024 after the company announced a $1.2 million registered direct offering of 6 million shares at $0.20 per share purchase price.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) shares fell 29.5% to $0.1839 after surging 29% on Wednesday. Synaptogenix received a Notice of Allowance for its U.S. Patent application 17/665,033 titled &quot;Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases.&quot;</li>
<li>Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell 26.8% to $11.25 after the company reported a wider-than-expected loss for its fourth quarter and announced plans to reduce its salaried workforce by around 10% to help further improve costs. The company said it sees production of 57,000 vehicles in 2024.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 23.2% to $1.0750.</li>
<li>Goosehead Insurance, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gshd#NASDAQ">GSHD</a>) dipped 21.2% to $68.78 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Bel Fuse Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/belfa#NASDAQ">BELFA</a>) fell 20.1% to $59.16 after the company reported weak fourth-quarter financial results.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) shares fell 19.1% to $2.9912 after the company reported mixed fourth-quarter financial results and issued guidance.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) dipped 18.6% to $9.52 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>ATN International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atni#NASDAQ">ATNI</a>) declined 18.1% to $29.20 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Pulmonx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lung#NASDAQ">LUNG</a>) fell 17.6% to $11.94 after the company reported fourth-quarter financial results.</li>
<li>MGP Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgpi#NASDAQ">MGPI</a>) declined 14.3% to $78.75 after the company reported fourth-quarter financial results.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares fell 13.1% to $0.5995 after declining around 7% on Wednesday.</li>
<li>Standard Motor Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smp#NYSE">SMP</a>) dipped 12.7% to $35.01 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Teekay Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tk#NYSE">TK</a>) gained 12.4% to $7.21 after the company reported a year-over-year decrease in Q4 financial results.</li>
<li>TrueCar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/true#NASDAQ">TRUE</a>) dipped 11% to $3.4450 following weak sales.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) fell 8% to $18.57. Kratos Defense &amp; Security Solutions announced a proposed public offering of $300 million of common stock.</li>
<li>Rogers Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rog#NYSE">ROG</a>) fell 6.8% to $108.29 following weak quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37262506/booking-holdings-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earni"> Booking Holdings Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACVA

AGRX

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ATNI

BBLG

BELFA

BZFD

DOCN

DPRO

EAST

ETSY

EZFL

GBNH

GSHD

INDV

KTOS

LCID

LNTH

LRHC

LUNG

MATV

MGPI

MNPR

MNTS

NOVA

NVAX

NVDA

OCUL

QTWO

RELY

RILY

RIVN

ROOT

RXRX

SMCI

SNPS

SNPX

TRUE

VERO

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares increased by 17.7% to $1.8 during Thursday's regular session. The market value of their outstanding shares is at $18.7 million. </li>
<li>FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) shares rose 17.61% to $223.6. The market value of their outstanding shares is at $7.9 billion. As per the press release, Q4 earnings came out today. </li>
<li>ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) shares increased by 17.01% to $16.38. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Tigo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYGO#NASDAQ">TYGO</a>) stock moved upwards by 14.5% to $1.5. The market value of their outstanding shares is at $88.1 million. </li>
<li>Ideal Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPWR#NASDAQ">IPWR</a>) shares rose 14.17% to $12.0. The company's market cap stands at $71.3 million. </li>
<li>Pixie Dust Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXDT#NASDAQ">PXDT</a>) shares rose 11.65% to $2.97. The market value of their outstanding shares is at $44.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock fell 17.6% to $0.41 during Thursday's regular session. The company's market cap stands at $33.7 million. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock decreased by 15.7% to $2.47. The market value of their outstanding shares is at $72.3 million. </li>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) shares decreased by 15.5% to $14.38. The company's market cap stands at $1.8 billion. </li>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) stock decreased by 14.5% to $0.59. The company's market cap stands at $7.0 million. </li>
<li>Sentage Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) stock fell 10.16% to $2.39. The company's market cap stands at $6.7 million. </li>
<li>Recruiter.Com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCRT#NASDAQ">RCRT</a>) shares decreased by 10.08% to $1.74. The company's market cap stands at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FLNC

IPWR

PXDT

RCRT

ROMA

SNTG

TYGO

VSTE

12 Industrials Stocks Moving In Thursday's Intraday Session

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Shares of NICE Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nice#NASDAQ">NICE</a>) rose sharply during Thursday&rsquo;s session after the company reported better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/news/earnings/24/02/37264405/nices-q4-results-surpasses-expectations-cloud-revenue-soars-sets-bold-2024-targets">issued FY24 guidance above estimates</a>.
NICE reported fourth-quarter fiscal 2023 revenue growth of 9.6% year-over-year to $623.19 million, beating the consensus of $618.51 million. Adjusted EPS improved to $2.36 compared to $2.04 in the prior year, beating the consensus of $2.28.
NICE shares jumped 10.4% to $249.39 on Thursday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) shares shares rose 40.8% to $12.21 after posting better-than-expected fourth-quarter results.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) gained 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax&#39;s prototype Covid-19 vaccine (NVX-COV2373).</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) climbed 27.6% to $15.00 following upbeat earnings.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) rose 26% to $4.0680 following upbeat results.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) climbed 22.2% to $9.19 after announcing a $325.0 million private placement.</li>
<li>Remitly Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rely#NASDAQ">RELY</a>) shares gained 19.5% to $21.13 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) climbed 19.3% to $18.13. B. Riley&rsquo;s board issued a statement regarding internal review.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) gained 19.2% to $875.07. Supermicro announced a proposed offering of $1.5 billion of convertible senior notes due 2029.</li>
<li>AlTi Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) jumped 18.6% to $6.90. AlTi Global announced a strategic investment of up to $450 million by Allianz X and Constellation Wealth Capital.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) gained 17.5% to $18.00 following strong sales results.</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) rose 16.9% to $16.37 after the company reported better-than-expected fourth-quarter financial results and announced the settlement of its antitrust litigation related to the AutoIMS technology platform.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) climbed 15.5% to $219.72 following upbeat results.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) gained 15.4% to $778.61 after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.</li>
<li>OUTFRONT Media Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/out#NYSE">OUT</a>) climbed 15.4% to $14.35 following upbeat results.</li>
<li>Lantheus Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnth#NASDAQ">LNTH</a>) gained 14.4% to $64.90 following strong results.</li>
<li>Indivior PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indv#NASDAQ">INDV</a>) rose 13.3% to $19.83 following fourth-quarter results.</li>
<li>Installed Building Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibp#NYSE">IBP</a>) gained 12.8% to $228.59 after the company reported better-than-expected fourth-quarter financial results and authorized a $300 million stock repurchase program.</li>
<li>ICON Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclr#NASDAQ">ICLR</a>) rose 12.1% to $319.05 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 guidance.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) climbed 11.6% to $41.51.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) rose 11.6% to $183.27 in sympathy with NVIDIA, which reported better-than-expected quarterly financial results and issued revenue guidance above estimates.</li>
<li>Quanta Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pwr#NYSE">PWR</a>) gained 11% to $234.42 after the company reported better-than-expected quarterly financial results and issued guidance.</li>
<li>Synopsys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) climbed 10.7% to $601.93 after the company reported better-than-expected first-quarter adjusted EPS results and issued strong guidance.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) gained 9.5% to $45.82 following strong results.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) gained 9.5% to $95.93 after the company reported fourth-quarter financial results.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) rose 8.7% to $88.46.</li>
<li>Wingstop Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wing#NASDAQ">WING</a>) gained 8.4% to $336.34. Wingstop reported better-than-expected results for its fourth quarter on Wednesday.</li>
<li>Royal Caribbean Cruises Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcl#NYSE">RCL</a>) surged 7.9% to $124.00 after the company raised its FY24 adjusted EPS guidance. Also, the company said demand and bookings has exceeded expectations.</li>
<li>DigitalOcean Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docn#NYSE">DOCN</a>) rose 6.8% to $38.29 following upbeat results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37254407/jim-cramer-unity-software-had-problems-but-zscaler-is-a-good-one-to-buy"> Jim Cramer: Unity Software &#39;Had Problems,&#39; But Zscaler Is A &#39;Good One&#39; To Buy </a>

ALTI

DELL

ICLR

MRNA

NICE

WING

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday

FTI Consulting shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 guidance.

2024 Guidance
The Company estimates that revenues for full year 2024 will range between $3.650 billion and $3.790 billion. The Company estimates that EPS for full year 2024 will range between $7.75 and $8.50. The Company does not currently expect Adjusted EPS to differ from EPS.

FTI Consulting FY24 Outlook: Revenue  $3.65B - $3.79B Vs. $3.70B Estimate, Adj. EPS $7.75 - $8.50 Vs. $8.20 Estimate

FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) reported quarterly earnings of $2.28 per share which beat the analyst consensus estimate of $1.67 by 36.53 percent. This is a 50 percent increase over earnings of $1.52 per share from the same period last year. The company reported quarterly sales of $924.68 million which beat the analyst consensus estimate of $840.40 million by 10.03 percent. This is a 19.40 percent increase over sales of $774.43 million the same period last year.

FTI Consulting Q4 Adj. EPS $2.28 Beats $1.67 Estimate, Sales $924.68M Beat $840.40M Estimate

FTI Consulting, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) today announced the appointment of&nbsp;<a href="https://www.globenewswire.com/Tracker?data=BAFjzET8Yj40InLwDLlR-qYn12Z4v5vuIvAisajVizGGFNifkhWzuHEt7vZYsH_nvFDQfPV2j3pgbd6d47ukgYqTeHHYLEL-NbeXA8E2SH4GXQPxTPV_h3SI1Q1Ca4KP" target="_blank">Go Matsumoto</a>&nbsp;as a Senior Managing Director within the Corporate Finance &amp; Restructuring segment in Tokyo. In addition,&nbsp;<a href="https://www.globenewswire.com/Tracker?data=Q_4E19sILCYnIpcYRZKGuZRG4kEVPuANcelK0MAABMA-g-zMt-Qa7NHJSAd3gE8YiiAdoY6I2v8EEb7B2eEnmyQ_h8OCe62u2R00HsnHKdkqiVAcALVztYdqJ9oVAoST" target="_blank">Eiji Michihiro</a>&nbsp;joined the segment in Tokyo as a Senior Advisor.

Government

Regulations

FTI Consulting Expands Corporate Finance & Restructuring Offering in Japan

Truist Securities analyst Tobey Sommer reiterates FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) with a Buy and maintains $240 price target.

Reiteration

Truist Securities Reiterates Buy on FTI Consulting, Maintains $240 Price Target

<h3>Gainers</h3>
<ul>
<li>Electriq Power Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELIQ#NYSE">ELIQ</a>) stock moved upwards by 35.0% to $0.91 during Thursday's regular session. As of 13:31 EST, Electriq Power Holdings's stock is trading at a volume of 224.7K, which is 21.6% of its average full-day volume over the last 100 days. The company's market cap stands at $34.6 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares moved upwards by 14.89% to $2.16. The market value of their outstanding shares is at $46.1 million. </li>
<li>FTI Consulting (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCN#NYSE">FCN</a>) stock increased by 14.25% to $210.15. As of 13:31 EST, this security is trading at a volume of 364.9K shares, making up 152.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.1 billion. The company's, Q3 earnings came out today. </li>
<li>View (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIEW#NASDAQ">VIEW</a>) shares increased by 12.57% to $3.96. The market value of their outstanding shares is at $16.0 million. </li>
<li>Applied UV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVIP#NASDAQ">AUVIP</a>) shares moved upwards by 9.82% to $2.62. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares increased by 8.38% to $3.75. The market value of their outstanding shares is at $93.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ultralife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULBI#NASDAQ">ULBI</a>) shares declined by 24.6% to $6.93 during Thursday's regular session. Trading volume for Ultralife's stock is 293.9K as of 13:31 EST. This is 104.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $111.9 million. As per the press release, Q3 earnings came out today. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) stock declined by 15.15% to $0.2. Nuvve Holding's stock is trading at a volume of 9.5 million shares as of 13:31 EST. This is 313.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.2 million. </li>
<li>TD Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLG#NASDAQ">GLG</a>) stock decreased by 14.39% to $0.07. Trading volume for TD Hldgs's stock is 3.7 million as of 13:31 EST. This is 53.4% of its average full-day volume over the last 100 days. The company's market cap stands at $14.0 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) shares declined by 13.32% to $0.74. Trading volume for Aqua Metals's stock is 493.9K as of 13:31 EST. This is 119.9% of its average full-day volume over the last 100 days. The company's market cap stands at $80.1 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock declined by 12.71% to $1.58. Trading volume for this security as of 13:31 EST is 120.1K, which is 83.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $209.6 million. </li>
<li>Primech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) stock decreased by 12.7% to $1.69. The current volume of 92.0K shares is 8.7% of Primech Holdings's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $59.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AQMS

AUVIP

ELIQ

MYNA

NVVE

PMEC

SCWO

ULBI

VIEW

<h3>Gainers</h3>
<ul>
<li>ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares jumped 231.6% to $2.8190 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) gained 77.8% to $0.3074. PaxMedica reported the completion of a type-B meeting with the FDA.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares surged 36.3% to $0.6250 after falling 21% on Wednesday. NextPlay Technologies received a notice from Nasdaq regarding delayed second-quarter report.</li>
<li>Mustang Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbio#NASDAQ">MBIO</a>) gained 33% to $2.1009. Mustang Bio announced FDA acceptance of IND application for MB-109, a novel combination of MB-101 and MB-108, for the treatment of recurrent glioblastoma and high-grade astrocytoma.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) jumped 31.6% to $0.3450. Mullen received favorable decision from Nasdaq Hearings Panel.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 31% to $65.06 after the company reported better-than-expected third-quarter revenue results.</li>
<li>The Singing Machine Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mics#NASDAQ">MICS</a>) gained 30% to $0.91.</li>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) rose 28.6% to $0.1662.</li>
<li>Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) shares climbed 26.8% to $0.1530 after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting.</li>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) gained 25% to $1.9499. La Rosa launched its proprietary AI technology system &#39;JAEME&#39; to support real estate agents.</li>
<li>Twin Ridge Capital Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trca#NYSE">TRCA</a>) rose 24% to $9.27.</li>
<li>Bel Fuse Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/belfb#NASDAQ">BELFB</a>) jumped 23.4% to $48.61 after the company reported third-quarter financial results.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) gained 22.8% to $74.44.</li>
<li>Endeavor Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edr#NYSE">EDR</a>) rose 22.2% to $21.65 after the company announced a review of strategic alternatives.</li>
<li>Jaguar Global Growth Corporation I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jggc#NASDAQ">JGGC</a>) shares climbed 21.7% to $8.01 after gaining over 18% on Wednesday.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 21.7% to $1.92. The FDA accepted ImmunityBio&#39;s resubmission of its Biologics License Application for N-803 as complete.</li>
<li>First Foundation Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ffwm#NYSE">FFWM</a>) rose 20.7% to $5.91 following upbeat quarterly results.</li>
<li>ProSomnus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osa#NASDAQ">OSA</a>) gained 19.7% to $0.7185.</li>
<li>Blueprint Medicines Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpmc#NASDAQ">BPMC</a>) gained 19.4% to $52.49 following strong quarterly results.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) rose 17.6% to $0.7876 after dipping 14% on Wednesday.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) jumped 17.3% to $9.40 following third-quarter results.</li>
<li>NETGEAR, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntgr#NASDAQ">NTGR</a>) rose 15.5% to $12.05 after the company reported better-than-expected third-quarter financial results.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) gained 15% to $0.4271. TransCode Therapeutics announced prolonged survival in murine models with glioblastoma treated with its lead candidate, TTX-MC138.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) rose 14.5% to $0.1382.</li>
<li>Sonic Automotive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sah#NYSE">SAH</a>) gained 12.8% to $48.92 following better-than-expected quarterly results.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) climbed 12.5% to $5.02 following third-quarter results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) gained 12.3% to $0.9996.</li>
<li>Mangoceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgrx#NASDAQ">MGRX</a>) shares jumped 12% to $0.8399 after falling around 14% on Wednesday. Mangoceuticals recently announced the official launch of MangoRx affiliate marketing program to enhance and accelerate topline growth.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) gained 12.1% to $206.23 following strong quarterly results.</li>
<li>Morningstar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/morn#NASDAQ">MORN</a>) rose 11.1% to $244.57 following third-quarter results.</li>
<li>Heidrick &amp; Struggles International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsii#NASDAQ">HSII</a>) rose 10.5% to $25.47 after the company reported better-than-expected quarterly financial results.</li>
<li>Willis Towers Watson Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtw#NASDAQ">WTW</a>) gained 10.3% to $229.11 after the company reported better-than-expected third-quarter results.</li>
<li>Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) jumped 8.4% to $9.73. Healthcare Services recently reported financial results.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) rose 7.8% to $11.52 after the company reported better-than-expected third-quarter revenue results. Additionally, the company raised FY23 revenue guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares fell 78.9% to $0.0970 as the company reported pricing of $5.04 million registered direct offering.</li>
<li>Sight Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sght#NASDAQ">SGHT</a>) dipped 53.3% to $1.6850. Sight Sciences is expected to report financial results for the third quarter on Nov. 7, 2023.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) fell 48.7% to $0.1901 as the company announced pricing of $1.7 million public offering of 8.5 million shares of common stock at a price of $0.20 per share.</li>
<li>Silicom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silc#NASDAQ">SILC</a>) fell 35.4% to $14.35 after the company issued weak sales forecast for the fourth quarter.</li>
<li>Lipella Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lipo#NASDAQ">LIPO</a>) declined 30.2% to $1.18.</li>
<li>SunCar Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sda#NASDAQ">SDA</a>) declined 29.9% to $8.10 after the company announced a $21 million follow-on offering of 2,567,238 shares at $8.18 per share.</li>
<li>LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) fell 29.4% to $0.1201.</li>
<li>BIO-key International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkyi#NASDAQ">BKYI</a>) declined 25.8% to $0.1706.</li>
<li>Nuvve Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvve#NASDAQ">NVVE</a>) fell 24.7% to $0.1799. Nuvve announced pricing of $2.066 million registered direct offering priced at-the-market.</li>
<li>Align Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algn#NASDAQ">ALGN</a>) fell 23.4% to $194.34 after the company reported worse-than-expected third-quarter financial results and issued guidance.</li>
<li>Theratechnologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thtx#NASDAQ">THTX</a>) shares fell 20.3% to $1.02 as the company reported pricing of $25 million public offering of common shares and concurrent private placement.</li>
<li>MaxLinear, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mxl#NASDAQ">MXL</a>) fell 17% to $15.28 after reporting downbeat results for the third quarter. Roth MKM downgraded MaxLinear from Buy to Neutral and lowered the price target from $35 to $18.</li>
<li>Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhat#NASDAQ">BHAT</a>) shares fell 16.2% to $2.28 after jumping over 33% on Wednesday. Fujian Blue Hat Interactive Entertainment Technology recently filed for a mixed shelf of up to $150 million.</li>
<li>Cognition Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgtx#NASDAQ">CGTX</a>) shares fell 15.7% to $1.0784 after gaining over 5% on Wednesday.</li>
<li>Whirlpool Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/whr#NYSE">WHR</a>) dropped 14.4% to $107.49 after the company reported third-quarter financial results and issued FY23 EPS guidance below estimates.</li>
<li>Expro Group Holdings N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpro#NYSE">XPRO</a>) declined 14.5% to $17.21 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Western Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdc#NASDAQ">WDC</a>) fell 14% to $36.26. Western Digital and Kioxia called off memory merger talks, Nikkei Asia reported.</li>
<li>Valmont Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vmi#NYSE">VMI</a>) declined 13.4% to $200.22 after the company reported third-quarter financial results and narrowed FY23 EPS guidance. Additionally, the company announced a realignment program and offered headcount reductions.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares fell 11.7% to $0.4369. Akili is expected to report its financial and operating results for the third quarter on Nov. 9, 2023.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>) declined 11.8% to $8.93 after the company reported worse-than-expected third quarter adjusted EPS results.</li>
<li>Simulations Plus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slp#NASDAQ">SLP</a>) declined 11.7% to $34.53 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Hasbro, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/has#NASDAQ">HAS</a>) fell 11.3% to $48.58 after the company reported worse-than-expected third-quarter financial results and said it expects FY23 revenue decline.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) declined 10.8% to $22.56. The company reported third-quarter financial results and issued FY23 guidance.</li>
<li>The Western Union Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wu#NASDAQ">WU</a>) declined 10.8% to $11.53. The company issued third-quarter financial results and narrowed FY23 adjusted EPS guidance.</li>
<li>Harley-Davidson, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hog#NYSE">HOG</a>) dropped 9.6% to $26.03 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Oceaneering International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oii#NYSE">OII</a>) declined 9.6% to $21.81 following weak quarterly sales.</li>
<li>West Pharmaceutical Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wst#NYSE">WST</a>) declined 9.5% to $323.99 following weak quarterly sales.</li>
<li>Mattel, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mat#NASDAQ">MAT</a>) shares fell 8.1% to $18.48 after reporting third-quarter results.</li>
<li>IM Cannabis Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) shares fell 8% to $0.55.</li>
<li>Comcast Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>) declined 6.4% to $40.03 after the company reported third-quarter financial results.</li>
<li>The Trade Desk, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttd#NASDAQ">TTD</a>) fell 6.1% to $67.30.</li>
<li>Meta Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meta#NASDAQ">META</a>) fell 2.3% to $292.55. Meta reported better-than-expected results for its third quarter. The company said it sees fourth-quarter revenue coming in a range of $36.5 billion to $40 billion.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35435755/more-than-246m-bet-on-occidental-petroleum-check-out-these-4-stocks-insiders-are-buying"> More Than $246M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying </a>

ABVC

AIRE

AKLI

ALGN

BELFB

BETS

BHAT

BKYI

BPMC

CANO

CGTX

CMCSA

FFWM

HCSG

HSII

IBRX

IMCC

JGGC

LIPO

LMDX

MBIO

MGRX

MICS

MMAT

MORN

MULN

NTGR

NXTP

OPRA

PXMD

RNAZ

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SGHT

SILC

SNOA

SWVL

THTX

TRCA

XPRO

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

FTI Consulting (FCN) has shared an announcement. FTI Consulting has presented several non-GAAP financial measures such as Adjusted EBITDA and Free ...

FTI Consulting Emphasizes Non-GAAP Measures for Performance Insights

FTI Consulting (FCN) just unveiled an announcement. FTI Consulting is set to discuss various non-GAAP financial measures in its upcoming call, whic...

FTI Consulting to Review Non-GAAP Measures for Performance Insight

In a report released today, Tobey Sommer from Truist Financial initiated coverage with a Buy rating on FTI Consulting (FCN – Research Report) and a...

FTI Consulting (FCN) Receives a New Rating from a Top Analyst

FTI Consulting GAAP EPS of $1.85 misses by $0.21, revenue of $926.02M misses by $20.14M

FTI Consulting, Inc. 2024 Q3 - Results - Earnings Call Presentation

FTI Consulting, Inc. (FCN) Q3 2024 Earnings Call Transcript

In a report released today, Tobey Sommer from Truist Financial maintained a Buy rating on FTI Consulting (FCN – Research Report). The company's sha...

FTI Consulting (FCN) Receives a Rating Update from a Top Analyst

FTI Consulting ( ($FCN) ) just unveiled an update. FTI Consulting reported a 3.7% increase in third-quarter 2024 revenues, reaching $926 million, d...

FTI Consulting's Q3 2024 Revenue Rises Amid Challenges

The latest announcement is out from FTI Consulting ( ($FCN) ). FTI Consulting's financial performance for Q3 2024 highlights the use of non-GAAP fi...

FTI Consulting Emphasizes Non-GAAP Measures in Q3 2024

The latest update is out from FTI Consulting ( ($FCN) ). FTI Consulting's recent earnings call revealed a weaker-than-expected performance in the t...

FTI Consulting Faces Q3 Challenges Amid Strategic Investments

Press Releases

General

FTI Consulting's Technology Segment Launches IQ.AI for Legal and Compliance

Management

FTI Consulting Adds Geopolitical Expert Jens Paulus as a Senior Managing Director

Organizations Are Least Prepared for Crises that Pose the Greatest Risk, According to FTI Consulting-Sponsored General Counsel Survey

Business Transformation Industry Leader Appointed to Lead FTI Consulting's North Asia Offering

FTI Consulting Reports Third Quarter 2024 Financial Results

AI Strategy Expert Brian Knudson Joins FTI Consulting

FTI Consulting Strengthens Forensic and Litigation Consulting Segment in Sydney with Two Senior Hires

FTI Consulting Expands Financial Services Practice with Appointment of  Two Senior Managing Directors

Change Management Expert Susanne Arndt Joins FTI Consulting as a Senior Managing Director

FTI Consulting Adds Two Industry Veterans to Corporate Reputation and Public Affairs Teams in Chicago

Comments

FTI Consulting

Notizie

Ultime notizie per FTI Consulting (NYSE:FCN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO